Haematology learning on-the-go, made by UK haematologists who know you're busy, tired, and possibly holding a sandwich. Whether you're commuting, tidying up, or too spent to open a book, we aim to deliver short episodes to fit into your daily grind. From blood basics to niche deep dives, there's something for students, specialists, and the haemo-curious. Most episodes are tightly scripted for a solo host, crafted to feel like a clear, helpful colleague talking it through. Designed to support evidence-based thinking habits that outlast outdated exam knowledge. New episodes most weeks.
Haemline
Claim This Podcastby Haemline Team
14 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇬🇧
23
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality46
Social0
YouTube0
Engagement0
Podcast Overview
Haematology learning on-the-go, made by UK haematologists who know you're busy, tired, and possibly holding a sandwich. Whether you're commuting, tidying up, or too spent to open a book, we aim to deliver short episodes to fit into your daily grind. From blood basics to niche deep dives, there's something for students, specialists, and the haemo-curious. Most episodes are tightly scripted for a solo host, crafted to feel like a clear, helpful colleague talking it through. Designed to support evidence-based thinking habits that outlast outdated exam knowledge. New episodes most weeks.
Language
🇺🇲
Publishing Since
6/30/2025
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
23
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality46
Social0
YouTube0
Engagement0
6
Excellent Areas
0
Good Performance
13
Growth Opportunities
excellent
Publishing Consistency
Every 3 days
Performing excellently!
poor
Episode Thumbnails
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Haemline
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
August 4, 2025
War of the Cords: Optimising Graft-versus-Leukaemia in Double Cord Blood Transplantation
In double cord blood transplantation, one unit engrafts and the other is rejected—but the losing unit might be doing more than previously imagined. A 2025 Blood Advances study from the Eurocord–EBMT registry reveals how the immunological battle between cord units can be redirected against leukaemia, particularly when the patient and losing unit share the right HLA mismatches. In this episode, we unpack the elegant biology behind this unintended vaccine effect, explore the surprising lack of e...
July 26, 2025
Deep Dive: Paediatric/AYA AML Transplant Decisions in the Molecular Era
Which children and young adults with acute myeloid leukaemia should receive transplant in first remission? This episode explores a landmark 2025 analysis from the Children's Oncology Group that revisits this longstanding question through a contemporary molecular lens. Huang and colleagues, publishing in the Journal of Clinical Oncology, analysed outcomes for over 1,400 patients from the AAML0531 and AAML1031 trials—studies that enrolled patients up to age 29. By retrospectively applying conte...
July 25, 2025
Rapid Review: Paediatric/AYA AML Transplant Decisions in the Molecular Era
Which children and young adults with acute myeloid leukaemia should receive transplant in first remission? In this Rapid Review, we explore a landmark analysis by Huang et al., published in the Journal of Clinical Oncology in April 2025. Reclassifying over 1,400 patients using AAML1831 criteria, the study offers a contemporary perspective on who gains from transplant—and who doesn't. The results are compelling: disease-free survival doubles for most molecularly defined high-risk patients, whi...
14 total episodes available
Deep-dive analytics for Haemline
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Haemline?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.